Skip to main content

Laura Donadeu Casassas

Institutions of which they are part

Main researcher
Nephrology and kidney transplantation
Vall Hebron Institut de Recerca

Laura Donadeu Casassas

Institutions of which they are part

Main researcher
Nephrology and kidney transplantation
Vall Hebron Institut de Recerca

Projects

Caracterización de la respuesta inmune celular específica frente al virus Epstein-Barr en receptores de trasplante renal pediátrico (CRICE-VEB)).

IP: Mercedes López González
Collaborators: Gema Ariceta Iraola, Laura Donadeu Casassas, Delphine Kervella
Funding agency: Sociedad Española de Trasplantes
Funding: 20000
Reference: SET/AYUDAS.PROYECTOS/2023/LOPEZ
Duration: 01/01/2024 - 31/12/2025

RESETTING THE IMMUNOLOGICAL SYSTEM OF HYPERSENSITIZED TRANSPLANT CANDIDATES TO ALLOW ACCESS TO HLA COMPATIBLE KIDNEY TRANSPLANTATION (RESET TRIAL)

IP: Oriol Bestard Matamoros
Collaborators: Ana Pérez González, Franc Casanova Ferrer, Elena Isabel Crespo Gimeno, Laura Donadeu Casassas, Clàudia Carrera Muñoz, Maria Antonia Emilia Meneghini, Delphine Kervella, Cristina Font Miñarro
Funding agency: Instituto de Salud Carlos III
Funding: 465456.69
Reference: ICI24/00066
Duration: 01/01/2025 - 31/12/2029

Assessment of natural antibodies in solid organ transplant

IP: Laura Donadeu Casassas
Collaborators: Miriam Izquierdo Sans
Funding agency: Instituto de Salud Carlos III
Funding: 20700
Reference: MV23/00037
Duration: 16/09/2024 - 13/12/2024

Disección y promoción de inmunidad adaptativa específica frente al poliomavirus (BKV) para prevenir la infección viral tras el trasplante renal (proyecto BK-VAX).

IP: Oriol Bestard Matamoros
Collaborators: Juliana Esperalba Esquerra, Joana Sellarés Roig, Emma Pardo De los Santos, Elena Isabel Crespo Gimeno, Laura Donadeu Casassas, Narcís Saubí Roca
Funding agency: Instituto de Salud Carlos III
Funding: 174240
Reference: PI22/01019
Duration: 01/01/2023 - 31/12/2025

Related news

The distinction from the Catalan Transplant Society will allow her to become a member of the Royal Academy of Medicine of Catalonia.

The Department of Health of the Generalitat de Catalunya grants subsidies for carrying out validation tests on innovative projects in the field of health that are in the early stages of development.

Hypertension, a key risk factor for heart disease that contributes significantly to cardiovascular mortality and morbidity and damage to vital organs, was the focus of this multi-centre study.

Related professionals

Glroia Soria Guerrero

Glroia Soria Guerrero

Research assistant
Transfusional Medicine
Read more
Lluc Tarruell Roma

Lluc Tarruell Roma

Research technician
Gene Therapy at Nervous System
Read more
Andrea Salvador Catalán

Andrea Salvador Catalán

Cardiovascular Diseases
Read more
Julia Sellares Nadal

Julia Sellares Nadal

Postdoctoral researcher
Infectious Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.